Search

everythinglearnresearchcommunity

for

Search:↓

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Alopecia areata affects 1 in 50 people, with non-White ethnic groups experiencing the most impact on mental health and work.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.

A young woman had surgery to remove a large hairball that blocked her intestines and then got psychiatric help.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Nyumi Happy Hair Gummies significantly improved hair growth, reduced hair fall, and enhanced nail health without side effects.

Alopecia areata requires addressing both emotional and financial challenges for better patient care.

More severe acne leads to a lower quality of life for teenagers.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Long COVID sufferers face significant challenges that need more public awareness and support.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Child abuse is linked to higher BMI, but not because of hair cortisol or cortisone levels.

Common skin conditions can greatly affect a person's mental health and social life.

Alopecia areata greatly affects people's life quality, mental health, and work life.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Combining homeopathy and supportive therapies improved hair growth and confidence in a 37-year-old man with hair loss.

Iranian girls in Isfahan typically start puberty around age 10, with menarche at 12.

Early detection, consistent management, and lifestyle changes are crucial for managing HAIR-AN syndrome effectively.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

Understanding hair health and disorders is important for effective treatment.

Hidradenitis suppurativa negatively affects patients' sexual lives and relationships, highlighting the need for better support and communication about sexual health.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Reducing accidents and treating vascular diseases can lower the need for life-impacting amputations.

New tools and criteria have been developed to better assess and treat pediatric lupus.